Discontinuation of antipsychotics during pregnancy is linked to a 60% increased risk for relapse in women with primary ...
Neurocrine Biosciences, Inc. today announced the presentation of new real-world evidence demonstrating that adult patients with tardive dyskinesia receiving INGREZZA® (valbenazine) capsules showed ...
BRENTWOOD, Tenn., April 14, 2026--(BUSINESS WIRE)--Trilliant Health, the healthcare industry’s leading analytics and market research firm, today released its 2026 Behavioral Health Report, finding ...
A pilot program that will allow a chatbot to authorize select psychiatric prescription refills while state regulators suspend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results